CATHI STEPHENS: Open Payments
NPI 1295158111 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$891 in 37 payments from 15 companies in 2025. Trend: 2023 $1,143 · 2024 $748 · 2025 $891
Food & beverage: $891
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $126 |
| Teva Pharmaceuticals USA, Inc. | 5 | $109 |
| ABBVIE INC. | 4 | $92 |
| Indivior Inc. | 4 | $80 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $76 |
| Vanda Pharmaceuticals Inc. | 2 | $71 |
| Axsome Therapeutics, Inc. | 2 | $57 |
| Alkermes, Inc. | 2 | $51 |
| Corium, LLC | 2 | $50 |
| Janssen Pharmaceuticals, Inc | 2 | $45 |
Products named: CAPLYTA, AUSTEDO XR, VRAYLAR, SUBLOCADE, REXULTI, HETLIOZ, Auvelity, LYBALVI.
Industry payments across FL — which companies pay providers there.
